What are the Challenges in Implementing PharmGKB in Pediatric Care?
Despite its potential benefits, several challenges exist:
Limited genetic data: There is a relative paucity of pharmacogenomic data specific to pediatric populations. Cost and accessibility: Genetic testing and implementation of personalized medicine can be expensive and may not be readily accessible to all patients. Ethical considerations: Issues such as consent, privacy, and the long-term implications of genetic testing need careful consideration. Education and training: Healthcare providers require adequate training to interpret and apply pharmacogenomic data effectively.
